SAMHD1 and hematopoietic and lymphoid cell neoplasm: Additional evidence pointed towards a similar effect for other antiproliferative drugs used to treat hematological cancers as fludarabine, decitabine, vidarabine, and clofarabine, all considered substrates of SAMHD1 [53], or forodesine an inhibitor of dGTP synthesis [54].